CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Virtual Care at HomeWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug1696 Opaganib Wiki 0.58
drug1822 Placebo Wiki 0.06

Correlated MeSH Terms (3)

Name (Synonyms) Correlation
D011014 Pneumonia NIH 0.06
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials

1 COVID-19 Virtual Care at Home

This multicentre prospective cohort trial is designed to demonstrate effectiveness and efficiency of a virtual care model for the management of COVID-19 patients isolating at home. The investigators have reoriented existing technology and networks for this research project. The investigators are amplifying our existing virtual care platform VIRTUES, combining it with home monitoring of COVID-19 patients, to provide real-time evidence, harmonize data collection, and share data provincially to mitigate the impact of the rapid spread of the virus. The study will facilitate early detection of complications associated with the disease, treatment and management of COVID-19 patients at home. The research will be conducted provincially in Ontario. This initiative will provide evidence to inform clinical and health system management and public health response to COVID-19 patients isolating at home.

NCT04420182 Cov Covid-19 Other: Virtual Care at Home

Primary Outcomes

Description: The primary outcome measure is patient satisfaction as measured from a patient satisfaction questionnaire at 28 days.

Measure: 28 Day Patient Satisfaction Questionnaire

Time: 28 days

Secondary Outcomes

Description: The secondary outcome measures will include the number of patients that require an Emergency Department visits during the observation period of 28 days.

Measure: Emergency Department Visits

Time: 28 days

Description: The secondary outcome measures will include the health status measures of the EuroQuality of Life Five Dimensions (EQ-5D-5L) at 28 days. Scoring is Level 1 to 5 for each dimension; higher scores meaning worse health status.

Measure: 28 Day EQ-5D-5L Scores

Time: 28 days

No related HPO nodes (Using clinical trials)